Watchlist Price Alert

Apimeds Pharmaceuticals U... (APUS)

NYSE: APUS · Real-Time Price · USD

1.74

0.11 (6.75%)

At close: Jun 23, 2025, 10:53 AM

Apimeds Pharmaceuticals US Inc Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-1.39M	-777.69K	-668.67K	-1.03M
Depreciation & Amortization	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	69.99K	193.54K	193.54K
Other Working Capital	538.75K	41.84K	-2.18K	2.84K
Other Non-Cash Items	117.72K	38.07K	29.14K	6.74K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	538.75K	41.84K	-2.18K	2.84K
Operating Cash Flow	-733.53K	-627.79K	-448.17K	-823.11K
Capital Expenditures	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a
Debt Repayment	250K	n/a	260K	400K
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	76.5K	-22.9K	22.9K	n/a
Financial Cash Flow	326.5K	1.03M	282.9K	400K
Net Cash Flow	-407.03K	404.31K	-165.27K	-423.11K
Free Cash Flow	-733.53K	-627.79K	-448.17K	-823.11K